本页面由Tiger Trade Technology Pte. Ltd.提供服务

Redhill Biopharma Ltd

0.5150
-0.0184-3.46%
盘后:0.5020-0.0130-2.52%19:49 EDT
成交量:8.21万
成交额:4.21万
市值:313.17万
市盈率:-3.79
高:0.5334
开:0.5145
低:0.5000
收:0.5335
52周最高:2.14
52周最低:0.4351
股本:608.09万
流通股本:608.09万
量比:0.03
换手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):-0.1358
每股收益(LYR):-0.1358
净资产收益率:-1708.61%
总资产收益率:-22.37%
市净率:-2.90
市盈率(LYR):-3.79

数据加载中...

2021/01/11

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2021/01/11

[补充]招股说明书

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2020/11/12

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/13

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/13

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/27

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/05/05

财报披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/26

非美公司披露报告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/04

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]